Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

AEGIS-2

Projekt: Typer af projekter

  1. ORION-8

    Projekt: Typer af projekter

  2. Determine 01 (HFpEF)

    Projekt: Typer af projekter

  3. Determine 02 (HFrEF)

    Projekt: Typer af projekter

  4. Dan-Heart

    Projekt: Typer af projekter

  5. Select

    Projekt: Typer af projekter

  6. DANBLOCK

    Projekt: Typer af projekter

  7. ODYSSEY LEGACY

    Projekt: Typer af projekter

  8. EFC14875/Scored

    Projekt: Typer af projekter

  9. LTOLE/COMPASS

    Projekt: Typer af projekter

  10. ORION-9

    Projekt: Typer af projekter

Vis graf over relationer
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-Group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome.
CSL112 is indicated to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in acute coronary syndrome (ACS) patients diagnosed with either ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) and exclusive of unstable angina, including those managed with percutaneous coronary intervention or medically managed.
StatusIgangværende
Periode01/11/201831/12/2021

ID: 55647886